Innovation Pharmaceuticals Inc (IPIX)

[georgejjl]

Brilacidin has been granted Fast Track by the FDA, which makes it eligible for more frequent FDA meetings, as well as potentially accelerated approval and priority review. The Company also plans to submit Brilacidin for FDA Breakthrough Therapy designation in the treatment of OM if results similar to those observed, at interim, continue to be seen through the conclusion of the study, planned to be completed in 4Q2017.

Good luck and GOD bless,

George